NeuroPro Therapeutics
PrivateLast Round
Early Funding
Mar 1, 2024
Total Funding Raised
$38M
Company Overview
NeuroPro Therapeutics is a biotechnology company that develops proprietary small molecule compounds to treat neurological diseases, including epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroPro Therapeutics Comparables
Compare NeuroPro Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IAMA Therapeutics | 77% | |
| Ovid Therapeutics Inc. | 77% | |
| EpilepsyGTx | 75% | |
NeuroPro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2024 | ||||
| Early Funding | Feb 1, 2023 |
NeuroPro Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fengate Asset Management | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 69% MoM, reaching 3.2K.
- Jan 20, 2026
Monthly visitors grew 150% MoM, reaching 1.7K.
NeuroPro Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroPro Therapeutics's valuation, stock price, and market status.